Loading clinical trials...
Loading clinical trials...
RATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studyi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Case Comprehensive Cancer Center
NCT07274397 · Glioblastoma, Brain Tumors, and more
NCT01269853 · Glioblastoma Multiforme, Anaplastic Astrocytoma
NCT07411690 · Brain Tumor Adult, Brain Tumor Benign, and more
NCT05342454 · Brain Tumor
NCT07418775 · Meningioma of Brain, Meningioma, and more
Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center
Cleveland, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions